Xiaoyuan Lu

5PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersGenomics and transcriptomicsCancer geneticsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 12, 2024
FHL1 Inhibition by miR-1301-3p Promotes Uterine Corpus Endometrial Carcinoma Cell Proliferation and Migration: A Prognostic Insight.

Mengna Zhu, Buze Chen, Lu Miao

|Jun 20, 2022
miR-149-3p Is a Potential Prognosis Biomarker and Correlated with Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.

Xiaoyuan Lu, Li Jing, Sicong Liu

|Sep 13, 2021
Expression, Clinical Significance, and Prospective Pathway Signaling of miR-501-3p in Ovarian Cancer Based on Database and Informatics Analysis.

Buze Chen, Xin Jin, Haihong Wang

|Jul 29, 2021
Bioinformatics Analysis of KIF1A Expression and Gene Regulation Network in Ovarian Carcinoma.

Xiaoyuan Lu, Guilin Li, Sicong Liu

|Apr 16, 2021
Differential Expression Profiles and Function Prediction of Transfer RNA-Derived Fragments in High-Grade Serous Ovarian Cancer.

Buze Chen, Sicong Liu, Haihong Wang

Pageof 1

Frequent Collaborators

4 joint publications

Buze Chen

1 joint publications

Hao Xu

1 joint publications

Xin Jin

1 joint publications

Mengna Zhu